Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2

被引:299
作者
Becker, I
Salaiza, N
Aguirre, M
Delgado, J
Carrillo-Carrasco, N
Kobeh, LG
Ruiz, A
Cervantes, R
Torres, AP
Cabrera, N
González, A
Maldonado, C
Isibasi, A
机构
[1] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 06726, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Fac Med, Dept Biol Celular & Tisular, Mexico City, DF, Mexico
[3] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim, Mexico City, DF, Mexico
[4] Ctr Med Nacl Siglo 21, Hosp Especialidades, Unidad Invest Med & Inmunoquim, IMSS, Mexico City, DF, Mexico
关键词
Leishmania major; innate immunity; TLR-2; cytokines;
D O I
10.1016/S0166-6851(03)00160-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Toll-like receptors (TLRs) mediate the cellular response to conserved molecular patterns shared by microorganisms. We report that TLR-2 on human NK cells is upregulated and stimulated by Leishmania major lipophosphoglycan (LPG), a phosphoglycan belonging to a family of unique Leishmania glycoconjugates. We found that purified L. major LPG upregulates both mRNA and the membrane expression of TLR-2 in NK cells. Additionally, IFN-gamma and TNF-alpha production and nuclear translocation of NF-kappaB was enhanced. The activation effect was more intense with LPG purified from infectious metacyclic parasites than from noninfectious procyclic Leishmania. Since the difference between the molecules derived from these two stages of the parasite growth cycle lies exclusively in the number of phosphosaccharide repeat domains and in the composition of glycan side chains that branch off these domains, we propose that TLR-2 possibly distinguishes between phosphorylated glycan repeats on LPG molecules. The effect of LPG on cytokine production and on membrane expression of TLR-2 could be blocked with F(ab')2 fragments of the mAb against LPG (WIC 79.3). Confocal microscopy demonstrated the co-localization of LPG and TLR-2 on the NK cell membrane. Binding of LPG to TLR-2 in NK cells was demonstrated by immunoprecipitations done with anti-TLR-2 and anti-LPG mAb followed by immunoblotting with anti-LPG and anti-TLR-2, respectively. Both antibodies recognized the immune complexes. These results suggest that NK cells are capable of recognition of, and activation by, Leishmania LPG through TLR-2, enabling them to participate autonomously in the innate immune system and thereby increasing the effective destruction of the parasite. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:65 / 74
页数:10
相关论文
共 52 条
[1]  
AKUFFO H, 1993, CLIN EXP IMMUNOL, V94, P516, DOI 10.1111/j.1365-2249.1993.tb08227.x
[2]   CYTOTOXICITY IN HUMAN MUCOSAL AND CUTANEOUS LEISHMANIASIS [J].
BARRALNETTO, M ;
BARRAL, A ;
BRODSKYN, C ;
CARVALHO, EM ;
REED, SG .
PARASITE IMMUNOLOGY, 1995, 17 (01) :21-28
[3]   TUMOR NECROSIS FACTOR-ALPHA IN COMBINATION WITH INTERFERON-GAMMA, BUT NOT WITH INTERLEUKIN-4 ACTIVATES MURINE MACROPHAGES FOR ELIMINATION OF LEISHMANIA-MAJOR AMASTIGOTES [J].
BOGDAN, C ;
MOLL, H ;
SOLBACH, W ;
ROLLINGHOFF, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (05) :1131-1135
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   Exploitation of the complement system by Leishmania promastigotes [J].
Brittingham, A ;
Mosser, DM .
PARASITOLOGY TODAY, 1996, 12 (11) :444-447
[6]  
CACERESDITTMAR G, 1993, CLIN EXP IMMUNOL, V91, P500, DOI 10.1111/j.1365-2249.1993.tb05931.x
[7]   Activation of toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite [J].
Campos, MA ;
Almeida, IC ;
Takeuchi, O ;
Akira, S ;
Valente, EP ;
Procópio, DO ;
Travassos, LR ;
Smith, JA ;
Golenbock, DT ;
Gazzinelli, RT .
JOURNAL OF IMMUNOLOGY, 2001, 167 (01) :416-423
[8]   Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice [J].
Carrera, L ;
Gazzinelli, RT ;
Badolato, R ;
Hieny, S ;
Muller, W ;
Kuhn, R ;
Sacks, DL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :515-526
[9]  
DESCOTEAUX A, 1991, J IMMUNOL, V146, P2747
[10]  
DESCOTEAUX A, 1992, J IMMUNOL, V149, P3008